BIOLASE Inc
OTC:BIOL

Watchlist Manager
BIOLASE Inc Logo
BIOLASE Inc
OTC:BIOL
Watchlist
Price: 0.0155 USD -10.92% Market Closed
Market Cap: 260k USD

BIOLASE Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

BIOLASE Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
BIOLASE Inc
OTC:BIOLQ
Revenue
$46m
CAGR 3-Years
9%
CAGR 5-Years
3%
CAGR 10-Years
-1%
Becton Dickinson and Co
NYSE:BDX
Revenue
$21.8B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Revenue
$19.4B
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Revenue
$24.4B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$43.8B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$9.6B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
15%
No Stocks Found

BIOLASE Inc
Glance View

Market Cap
260k USD
Industry
Health Care

BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. The company is headquartered in Foothill Ranch, California and currently employs 158 full-time employees. The firm develops, manufactures, markets and sells laser systems, which provides helps to dental practitioners and their patients. The Company’s systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons and other dental specialists to perform a range of dental procedures, including cosmetic, restorative and complex surgical applications. The company offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft tissue) systems. Its Waterlase brand uses a patented combination of water and laser energy and performs using drills, scalpels and other traditional dental instruments for cutting soft and hard tissue. The company offers its diode laser systems to perform soft tissue, pain therapy and cosmetic procedures, including teeth whitening. The company has approximately 301 issued and 38 pending United States and international patents.

BIOL Intrinsic Value
Not Available

See Also

What is BIOLASE Inc's Revenue?
Revenue
46m USD

Based on the financial report for Sep 30, 2024, BIOLASE Inc's Revenue amounts to 46m USD.

What is BIOLASE Inc's Revenue growth rate?
Revenue CAGR 10Y
-1%

Over the last year, the Revenue growth was -7%. The average annual Revenue growth rates for BIOLASE Inc have been 9% over the past three years , 3% over the past five years , and -1% over the past ten years .

Back to Top